NCT06814236

Brief Summary

In Anaesthesia Practice, an Informed consent involves discussing the risks and benefits involved with a certain procedure and its alternatives. Though it is intended to promote patient autonomy and enhance decision-making, the risk profiling, detailing and discussing; generally walks one-way, from the anaesthesiologist to patient/party. This monologue-leaned communication is neither free flowing nor the patients are allowed to 'speak-up-first' on their concerns or queries. Several gaps can be identified including reluctance on the part of the anaesthesiologist to engage the patients in decision making or not upholding the patient preferences; or patient lacking sufficient knowledge to make an informed choice. Therefore, for risk communication, the very context has to be tailored to patient's individual needs. There is no available study till date which has tried to address as how the communication between patient and the anaesthesiologist is influenced by the 'gender' of the patient concerned. This situates a need to understand how the 'gender' of a patient can influence communication during an Informed consent conversation on anaesthesia risk(s). The study will explore to decipher if difference(s) in patient's gender influence their perceptions and understanding of anesthesia-related risks, and if the difference will influence the future lines of communication involving either of the gender. This prospective study will be based on conversation model based interview designed to assess the nuances of gender- based differences in risk perception and information exchange during pre-anaesthetic consultations.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Dec 2027

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
2.8 years until next milestone

Study Start

First participant enrolled

December 1, 2027

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

February 1, 2025

Last Update Submit

April 21, 2026

Conditions

Keywords

genderanaesthesia riskinformed consent

Outcome Measures

Primary Outcomes (1)

  • Pre-informed Gender

    Based on 3-stage informed consent conversation model it will be assessed which gender 'male' or 'female' is pre-informed about anaesthesia concerns and risks when asked

    From beginning of preoperative period to beginning of surgery

Secondary Outcomes (3)

  • Gender Curosity For Anesthesia Risk Factors

    From beginning of preoperative period to beginning of surgery

  • Gender Perusal for Anaesthesia & Surgical Risk Details

    From beginning of preoperative period to beginning of surgery

  • Doctor-patient relationship type

    From beginning of preoperative period to beginning of surgery

Study Arms (2)

Males

Patients undergoing elective short-to-moderate duration surgery will be administered a questionnaire based interview at the time of obtaining informed consent

Behavioral: Three-Stage Informed Consent Conversation Model for Anaesthesia Risk profiling

Females

Patients undergoing elective short-to-moderate duration surgery will be administered a questionnaire based interview at the time of obtaining informed consen

Behavioral: Three-Stage Informed Consent Conversation Model for Anaesthesia Risk profiling

Interventions

Stage 1 Pre-information queries Do you know about the risks involved in Anaesthesia? If yes, where did you get information about the risks involved with Anaesthesia?? Which of these do you already know of and what concerns you most? Why are you concerned more about that particular risk factor? Stage 2 Informing Risks The probability or chances of supposed anaesthesia risks could be: Probable risk Possible risk Remote risk We have the following risk management strategy in place for your reassurance and safety: Employing ERAS protocol The surgery you are going to undergo, also may have its own set of risks Stage 3 Post-information Informing Risks In view of the above conversation we had, do you have other point of concern or query on what we have talked about.

FemalesMales

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients undergoing elective surgical procedure under anaesthesia

You may qualify if:

  • Male and Female patients
  • Posted for short-2-moderate duration surgery
  • Willing to participate
  • Education \> Bachelors degree
  • ASA -I \& II physical grade

You may not qualify if:

  • Patients posted for major surgery
  • Patients in for emergency surgery
  • ASA III-IV physical grade.
  • Patients refusing recording of the interview
  • Those looking to their family members to decide upon whether to participate in study • Patients agreeing to recording of the interview but refusing the recorded interview to be evaluated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sir Ganga Ram Hospital

New Delhi, National Capital Territory of Delhi, 110060, India

Location

Sir Ganga Ram Hospital

New Delhi, National Capital Territory of Delhi, 110060, India

Location

MeSH Terms

Conditions

Coitus

Condition Hierarchy (Ancestors)

Sexual BehaviorBehavior

Study Officials

  • Jyotsana Sharma, MSc

    Sir Ganga Ram Hospital, New Delhi-110060, India

    PRINCIPAL INVESTIGATOR
  • Amitabh Dutta, MD

    Sir Ganga Ram Hospital, New Delhi-110060, India

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant

Study Record Dates

First Submitted

February 1, 2025

First Posted

February 7, 2025

Study Start (Estimated)

December 1, 2027

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations